Abstract:To investigate whether the microRNA-144 (miR-144) had immune regulation effect on matured immune cells, we firstly used quantitative RT-PCR (qRT-PCR) to detect the expression changes of miR-144 between the matured and immature dendritic cells (DCs), macrophages, and the peripheral blood mononuclear cells (PBMCs). Then we went on inspecting the expression changes of TNF-alpha, IL-1 beta, IL-6 and IL-23 in the matured DCs treated with miR-144 mimics or inhibitors using qRT-PCR, and also performed western blot to test phosphorylation state of ERK, JNK, p38 and p65 in these cells. Next, TargetScan was conducted to forecast the target gene of miR-144, receptor activator for nuclear factor-KB ligand (RANKL), and double luciferase reporter system was applied to research their banding sites. We also determined the expression changes of RANKL in the DCs treated with miR-144 mimics or inhibitors using qRT-PCR and ELISA, respectively. The siRNA of RANKL was synthesized and transfected into DCs to inspect how the immune regulation effect of miR-144 was conducted to inhibit the expression of TNF-alpha using qRT-PCR, and lastly we used flow cytometry to investigate whether this effect applied to Th17 cells. As results, we found that miR-144 was down-regulated in the matured DCs, macrophages and PBMCs of liver transplantation patients, and the miR-144 mimics could inhibit the expression levels of TNF-alpha, IL-1 beta, IL-6 and IL-23 in the matured DCs. Furthermore, miR-144 interacted with RANKL at position 679-685 of RANKL 3'UTR, and suppressed the translation of RANKL mRNA to realize the negative-regulation. Besides, the silence of RANKL enhanced the suppression effect of miR-144 on TNF-alpha and this immune regulation effect was applied to Th17 cells, too. In conclusion, this study clearly illustrated that miR-144 could inhibit the expression of cytokine in matured immune cells through suppressing the translation of RANKL mRNA.

MiR-34a Promotes DCs Development and Inhibits Their Function on T Cell Activation by Targeting WNT1

Mir-34a promotes the development of dendritic cells and inhibits the function of DC on activating the CD4+ T cells by inducing high expression of IL-17 (HEM5P.237)

Microrna-181A Represses Ox-Ldl-stimulated Inflammatory Response in Dendritic Cell by Targeting C-Fos

Transcription factor E2F1 suppresses dendritic cell maturation.

Transcription factor E2F1 suppresses dendritic cell maturation. (167.3)

Integrin CD11b Negatively Regulates TLR9-triggered Dendritic Cell Cross-Priming by Upregulating Microrna-146A.

MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation

Mir-34A Expands Myeloid-Derived Suppressor Cells Via Apoptosis Inhibition

Mir‐34a Inhibits the Apoptosis of MDSCs by Suppressing the Expression of N‐myc

The development and function of dendritic cell populations and their regulation by miRNAs

MicroRNAs Regulate Dendritic Cell Differentiation and Function

TGF Β1 Inhibits the Maturation of Dendritic Cells and Down- Regulates TLR4 Expression

Loss of miR-146a skews the dendritic cell milieu in favor of CD8a+CD103+ cross-presenting migratory dendritic cells and reduces production of IL-27

MicroRNA-144 Suppresses the Expression of Cytokines Through Targeting RANKL in the Matured Immune Cells.

TGF-β-associated Mir-27A Inhibits Dendritic Cell-Mediated Differentiation of Th1 and Th17 Cells by TAB3, P38 MAPK, MAP2K4 and MAP2K7

miRNomes of haematopoietic stem cells and dendritic cells identify miR-30b as a regulator of Notch1

[Effects of Vascular Endothelial Growth Factor on Differentiation and Function of Dendritic Cells Generated from CD34+ Hematopoietic Progenitor Cells in Vitro].

MiR‐199a‐3p modulates the function of dendritic cells involved in transplantation tolerance by targeting CD86

MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages

Mir-15a Promotes Phenotypic And Functional Maturation Of Lps-Induced Dendritic Cells Through Down-Regulating Ddx39 Expression

miR-146a −/− deficiency in the DC compartment results in increased effector phenotype CD4+ and CD8+ T cells in response to LCMV infection